1. Home
  2. ARCT vs SMBK Comparison

ARCT vs SMBK Comparison

Compare ARCT & SMBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • SMBK
  • Stock Information
  • Founded
  • ARCT 2013
  • SMBK N/A
  • Country
  • ARCT United States
  • SMBK United States
  • Employees
  • ARCT N/A
  • SMBK N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • SMBK Major Banks
  • Sector
  • ARCT Health Care
  • SMBK Finance
  • Exchange
  • ARCT Nasdaq
  • SMBK Nasdaq
  • Market Cap
  • ARCT 320.8M
  • SMBK 602.3M
  • IPO Year
  • ARCT N/A
  • SMBK N/A
  • Fundamental
  • Price
  • ARCT $18.05
  • SMBK $36.83
  • Analyst Decision
  • ARCT Strong Buy
  • SMBK Buy
  • Analyst Count
  • ARCT 10
  • SMBK 4
  • Target Price
  • ARCT $50.88
  • SMBK $37.25
  • AVG Volume (30 Days)
  • ARCT 493.8K
  • SMBK 40.8K
  • Earning Date
  • ARCT 11-06-2025
  • SMBK 10-20-2025
  • Dividend Yield
  • ARCT N/A
  • SMBK 0.87%
  • EPS Growth
  • ARCT N/A
  • SMBK 62.51
  • EPS
  • ARCT N/A
  • SMBK 2.47
  • Revenue
  • ARCT $122,122,000.00
  • SMBK $178,959,000.00
  • Revenue This Year
  • ARCT N/A
  • SMBK $22.86
  • Revenue Next Year
  • ARCT $28.92
  • SMBK $10.59
  • P/E Ratio
  • ARCT N/A
  • SMBK $14.91
  • Revenue Growth
  • ARCT N/A
  • SMBK 20.51
  • 52 Week Low
  • ARCT $8.04
  • SMBK $26.31
  • 52 Week High
  • ARCT $25.88
  • SMBK $37.82
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 58.87
  • SMBK 54.98
  • Support Level
  • ARCT $16.54
  • SMBK $36.17
  • Resistance Level
  • ARCT $19.50
  • SMBK $37.57
  • Average True Range (ATR)
  • ARCT 1.08
  • SMBK 0.72
  • MACD
  • ARCT -0.08
  • SMBK -0.11
  • Stochastic Oscillator
  • ARCT 56.46
  • SMBK 39.89

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About SMBK SmartFinancial Inc.

SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.

Share on Social Networks: